175 related articles for article (PubMed ID: 7697602)
1. Quantitative histopathology in ductal carcinoma of the breast. Prognostic value of mean nuclear size and mitotic counts.
Ladekarl M
Cancer; 1995 Apr; 75(8):2114-22. PubMed ID: 7697602
[TBL] [Abstract][Full Text] [Related]
2. Quantitative histopathology in lymph node-negative breast cancer. Prognostic significance of mitotic counts.
Ladekarl M; Jensen V
Virchows Arch; 1995; 427(3):265-70. PubMed ID: 7496595
[TBL] [Abstract][Full Text] [Related]
3. Prognostic, quantitative histopathologic variables in lobular carcinoma of the breast.
Ladekarl M; Sørensen FB
Cancer; 1993 Nov; 72(9):2602-11. PubMed ID: 8402482
[TBL] [Abstract][Full Text] [Related]
4. Quantitative histopathology in the prognostic evaluation of patients with transitional cell carcinoma of the urinary bladder.
Sasaki M; Sørensen FB; Fukuzawa S; Yamabe H; Olsen S; Yoshida O
Cancer; 1993 Oct; 72(8):2470-83. PubMed ID: 8402464
[TBL] [Abstract][Full Text] [Related]
5. Quantitative histopathological variables in in situ and invasive ductal and lobular carcinomas of the breast.
Ladekarl M; Sørensen FB
APMIS; 1993 Dec; 101(12):895-903. PubMed ID: 8110444
[TBL] [Abstract][Full Text] [Related]
6. Objective malignancy grading: a review emphasizing unbiased stereology applied to breast tumors.
Ladekarl M
APMIS Suppl; 1998; 79():1-34. PubMed ID: 9645191
[TBL] [Abstract][Full Text] [Related]
7. Grading and prognosis of infiltrating ductal breast carcinoma by mean nuclear volume estimates.
Roldán-Villalobos R; Artacho-Pérula E; Ruiz-Moruno FJ
Anal Quant Cytol Histol; 1996 Apr; 18(2):158-66. PubMed ID: 8744506
[TBL] [Abstract][Full Text] [Related]
8. The influence of tissue processing on quantitative histopathology in breast cancer.
Ladekarl M
J Microsc; 1994 May; 174(Pt 2):93-100. PubMed ID: 8051699
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of mitotic figures in metastatic mammary ductal carcinoma to the lymph nodes.
Hasebe T; Iwasaki M; Akashi-Tanaka S; Hojo T; Shibata T; Sasajima Y; Kinoshita T; Tsuda H
Hum Pathol; 2011 Dec; 42(12):1823-32. PubMed ID: 21683981
[TBL] [Abstract][Full Text] [Related]
10. S-phase fraction and nuclear size in long term prognosis of patients with breast cancer.
Meyer JS; Province MA
Cancer; 1994 Oct; 74(8):2287-99. PubMed ID: 7922981
[TBL] [Abstract][Full Text] [Related]
11. Stereologic estimates of volume-weighted mean nuclear volume in aspiration smears of ductal breast carcinoma. Correlation with cytologic grade, tumor size and lymph node status.
Martín R; Sneige N; Vásquez M; Aragón-Flores M; Martín G; Marrón C; Santamaría L
Anal Quant Cytol Histol; 1999 Jun; 21(3):185-93. PubMed ID: 10560490
[TBL] [Abstract][Full Text] [Related]
12. [Proliferation index and its prognostic value in invasive ductal breast carcinoma].
Falco M
Ann Acad Med Stetin; 2009; 55(1):22-30. PubMed ID: 20349588
[TBL] [Abstract][Full Text] [Related]
13. Loss of nuclear localized and tyrosine phosphorylated Stat5 in breast cancer predicts poor clinical outcome and increased risk of antiestrogen therapy failure.
Peck AR; Witkiewicz AK; Liu C; Stringer GA; Klimowicz AC; Pequignot E; Freydin B; Tran TH; Yang N; Rosenberg AL; Hooke JA; Kovatich AJ; Nevalainen MT; Shriver CD; Hyslop T; Sauter G; Rimm DL; Magliocco AM; Rui H
J Clin Oncol; 2011 Jun; 29(18):2448-58. PubMed ID: 21576635
[TBL] [Abstract][Full Text] [Related]
14. DNA level and stereologic estimates of nuclear volume in squamous cell carcinomas of the uterine cervix. A comparative study with analysis of prognostic impact.
Sørensen FB; Bichel P; Jakobsen A
Cancer; 1992 Jan; 69(1):187-99. PubMed ID: 1727663
[TBL] [Abstract][Full Text] [Related]
15. The prognostic significance of epidermal growth factor receptor expression in breast cancer.
Noguchi M; Mizukami Y; Kinoshita K; Earashi M; Thomas M; Miyazaki I
Surg Today; 1994; 24(10):889-94. PubMed ID: 7894186
[TBL] [Abstract][Full Text] [Related]
16. Objective malignancy grading of squamous cell carcinoma of the lung. Stereologic estimates of mean nuclear size are of prognostic value, independent of clinical stage of disease.
Ladekarl M; Bæk-Hansen T; Henrik-Nielsen R; Mouritzen C; Henriques U; Sørensen FB
Cancer; 1995 Sep; 76(5):797-802. PubMed ID: 8625182
[TBL] [Abstract][Full Text] [Related]
17. Fibrotic focus in invasive ductal carcinoma of the breast: a histopathological prognostic parameter for tumor recurrence and tumor death within three years after the initial operation.
Hasebe T; Tsuda H; Tsubono Y; Imoto S; Mukai K
Jpn J Cancer Res; 1997 Jun; 88(6):590-9. PubMed ID: 9263537
[TBL] [Abstract][Full Text] [Related]
18. Comparative predictive value of three prognostic markers--S-phase fraction, PCNA and Mitotic count on axillary lymph node metastasis in carcinoma breast.
Pervez S; Khan MN; Nasir MI
J Ayub Med Coll Abbottabad; 2007; 19(1):3-5. PubMed ID: 17867469
[TBL] [Abstract][Full Text] [Related]
19. Nuclear morphometry and mitotic indexes as prognostic factors in breast cancer.
Aaltomaa S; Lipponen P; Eskelinen M; Alhava E; Syrjänen K
Eur J Surg; 1991 May; 157(5):319-24. PubMed ID: 1678644
[TBL] [Abstract][Full Text] [Related]
20. A proposal for a new histological classification scheme for predicting short-term tumor recurrence and death in patients with invasive ductal carcinoma of the breast.
Hasebe T; Imoto S; Sasaki S; Mukai K
Jpn J Cancer Res; 1998 Dec; 89(12):1358-73. PubMed ID: 10081498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
